2022
DOI: 10.3389/fonc.2022.845636
|View full text |Cite
|
Sign up to set email alerts
|

Development of a Novel Reference Material for Tumor Mutational Burden Measurement Based on CRISPR/Cas9 Technology

Abstract: As a biomarker that affects treatment decisions of immune checkpoint inhibitors, the accuracy, reliability, and comparability of tumor mutational burden (TMB) estimation is of paramount importance. To improve the consistency and reliability of these tests, qualified reference materials providing ground-truth data are crucial. In this study, we developed a set of formalin-fixed and paraffin-embedded (FFPE) samples with different TMB values as the novel reference materials for TMB estimation. By introducing seve… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 38 publications
0
1
0
Order By: Relevance
“…The four original cell line gDNA samples (A1, B1, C1, D1) used in this study originated from the 293T cell line and were edited to generate and accumulate random gene mutations 43 . The gDNA from the original 293T without induced mutations was used to simulated the paired normal sample.…”
Section: Methodsmentioning
confidence: 99%
“…The four original cell line gDNA samples (A1, B1, C1, D1) used in this study originated from the 293T cell line and were edited to generate and accumulate random gene mutations 43 . The gDNA from the original 293T without induced mutations was used to simulated the paired normal sample.…”
Section: Methodsmentioning
confidence: 99%